Véronique Orian-Rousseau

8PUBLICATIONS
45CO-AUTHORS
Cancer diagnosisAutoimmunityHaematological tumoursGlycoconjugatesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 15, 2026
Loss of CD44 re-educates pancreatic cancer-associated fibroblasts modulating their fibrotic and immunosuppressive functions.

|Jan 14, 2025
CD44 in myeloid cells is a major driver of liver inflammation and injury in alcohol-associated liver disease.

Déborah Rousseau, Stéphanie Bonnafous, Frédéric Soysouvanh

|Oct 04, 2024
CD44: a stemness driver, regulator, and marker-all in one?

Steffen J Sonnentag, Nagwa S M Ibrahim, Veronique Orian-Rousseau

|Jul 17, 2024
High-throughput screening for cell binding and repulsion peptides on multifunctionalized surfaces.

Steffen J Sonnentag, Felix Jenne, Véronique Orian-Rousseau

|May 18, 2024
Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis.

Lisa-Marie Mehner, Leonel Munoz-Sagredo, Steffen Joachim Sonnentag

|Jul 31, 2023
Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy.

Mengwu Pan, Valeria Solozobova, Nane C Kuznik

Pageof 2

Frequent Collaborators

2 joint publications

Marwin A Farrugia

2 joint publications

Yvonne Madeleine Heneka

1 joint publications

Leonel Munoz-Sagredo

1 joint publications

Karolin Streule